Last Posted: Dec 13, 2018
- Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.
DiBattista Alicia et al. Journal of proteome research 2018 Dec - Prenatal Diagnosis of Cystic Fibrosis.
Fedick Anastasia M et al. Methods in molecular biology (Clifton, N.J.) 2019 1885221-231 - A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults
M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018 - Gene therapy for sickle cell disease.
Olowoyeye Abiola et al. The Cochrane database of systematic reviews 2018 Nov 11CD007652 - Implementing Genomics-Based Screening Programs for Healthy Adults: A Proposed Evidence-based Approach from the Genomics and Population Health Action Collaborative
Khoury MJ et al, Blog Post, December 3, 2018 - Expanded carrier screening for monogenic disorders: where are we now?
Chokoshvili Davit et al. Prenatal diagnosis 2018 38(1) 59-66 - Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.
Sharma Neeraj et al. PLoS genetics 2018 Nov 14(11) e1007723 - Devil in the detail of newborn screening for cystic fibrosis.
Doull Iolo et al. Archives of disease in childhood 2018 Nov - Noninvasive paternal exclusion testing for cystic fibrosis in the first five to eight weeks of gestation.
Zeevi David A et al. Scientific reports 2018 Oct 8(1) 15941 - Pharmacogenomics: What does it mean for your health
CDC, October 2018
No hay comentarios:
Publicar un comentario